Comparision Between Activated Partial Thromboplastin Time Versus Anti-Xa Activity in Heparin Monitoring
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 700 participants.
Also called NCT03426982
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose supportive care
- Phase
- Phase 4
- Enrolled
- 700 participants
- Sponsor
- Registry
-
NCT03426982
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT03426982. Randomized; no masking; primary purpose supportive care. Start 2018-03-01 (actual); primary completion 2018-10-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparision Between Activated Partial Thromboplastin Time Versus Anti-Xa Activity in Heparin Monitoring
- Acronym
- CATCH
- Condition
- Myocardial Infarction
- Condition
- Venous Thromboembolism
- Condition
- Stroke
- Condition
- Bleeding
- Intervention (Drug)
- Unfractionated heparin
- Intervention (Drug)
- Unfractionated heparin
- Lead sponsor
- Wuhan Asia Heart Hospital
Record details
- Record id
cardio:ct-nct03426982- Content hash
c8dc95453b5a73dbbcde96c2f236b8b93f760233cac418e405e9cb3681c4299b